Achieve More by Successfully Navigating the New World of 340B Contract Pharmacy

Importance of transparency when addressing a changing 340B environment.


By: Heather Easterling and Andrew Wilson

Read time: 1 minute

Since 2020, drug manufacturers have implemented policies restricting the purchase of 340B-priced drugs for covered entities when dispensing through contract pharmacies and the result is contributing to financial losses for safety-net hospitals.

Watch the 340B Tips, Tricks, and Traps webinar as we explore this ever-changing environment and how transparency is at the center of it all.

Subscribe to our monthly Prescribed Perspectives newsletter to have our exclusive content delivered directly to your inbox!